Inventor
Dalin Tang
Inventor
Shrewsbury, MA, US
Overview
Patents· 5 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Bprimary
A61BDiagnosis17%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations17%
C07BGeneral methods of organic chemistry17%
C07DHeterocyclic compounds17%
G16HHealthcare informatics, i.e. information and communication technology [ict] specially adapted for the handling or processing of medical or healthcare data17%
G06TImage data processing or generation, in general8%
Y02ATechnologies for adaptation to climate change8%
PatentTitleYear
10,562,852Crystalline forms of (R)-1-(1-(methylsulfonyl)propan-2-yl)-4-(trifluoromethyl)-1H-indole-5-carbonitrile20209,902,694'Crystalline forms'20188,718,944'Patient-specific image-based computational modeling and techniques for human heart surgery optimization'20148,554,490'Automatic vascular model generation based on fluid-structure interactions (FSI)'20137,751,984'Image-based computational mechanical analysis and indexing for cardiovascular diseases'2010Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2010–2014Patents assigned to WORCESTER POLYTECH INST (3)· patent assignee history
2010–2014Based in Shrewsbury, MA, US· patent location history
2013–2014Patents assigned to TANG DALIN (2)· patent assignee history
2013Patents assigned to TENG ZHONGZHAO (1)· patent assignee history
2018–2020Patents assigned to GLAXOSMITHKLINE IP NO 2 LTD (2)· patent assignee history
2018–2020Based in Shanghai, CN· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| WORCESTER POLYTECH INST | 3 | 2010–2014 |
| GLAXOSMITHKLINE IP NO 2 LTD | 2 | 2018–2020 |
| TANG DALINself | 2 | 2013–2014 |
| TENG ZHONGZHAO | 1 | 2013 |
Locations
| Location | Patents | Span |
|---|---|---|
| Shrewsbury, Massachusetts, US | 3 | 2010–2014 |
| Shanghai, CN | 2 | 2018–2020 |